Lilly’s Olumiant posts trial win in autoimmune hair loss, setting up potential first-in-class FDA nod

Lilly’s Olumiant posts trial win in autoimmune hair loss, setting up potential first-in-class FDA nod
esagonowsky
Wed, 03/03/2021 – 09:37